Point-of-care (POC) advertising delivers pharmaceutical messaging directly within electronic health record (EHR) systems and clinical workflow tools at the moment physicians are making treatment decisions. The promise is compelling: reach the physician exactly when they are writing prescriptions, with messaging that can influence their clinical choice in real time. But does this theoretical advantage translate into measurable prescribing impact? This analysis examines the evidence behind EHR point-of-care advertising, evaluating platform capabilities, cost structures, and the often-mixed results of script impact studies.
What Is Point-of-Care Advertising?
Point-of-care advertising refers to pharmaceutical promotional messages delivered through clinical technology platforms that physicians use during patient encounters. These platforms include EHR-embedded messaging, clinical decision support systems, e-prescribing interfaces, and physician-facing mobile applications. The defining characteristic of POC advertising is that it reaches physicians during their clinical workflow, ideally at or near the moment of treatment decision-making.
The POC advertising category has grown significantly as EHR systems have become ubiquitous in American healthcare. With over 95% of office-based physicians now using EHR systems, the potential reach of POC advertising has expanded dramatically. However, the actual implementation of advertising within clinical workflows remains limited by EHR vendor policies, physician resistance to interruptions, and regulatory considerations about commercial influence during patient care.
Major POC Advertising Platforms
The POC advertising landscape is served by several platform categories, each with different positioning, reach, and targeting capabilities.
| Platform | Type | Physician Reach | Targeting Capability | Primary Ad Format |
|---|---|---|---|---|
| Epocrates (Athenahealth) | Clinical reference app | 300K+ physicians | Specialty, condition, formulary | Banner, native content, alerts |
| Doximity Dialer | Telehealth/communication tool | 500K+ physicians | Specialty, location, NPI | In-call messaging, post-call display |
| Sermo | Physician social platform | 150K-300K MAU | Specialty, discussion topic | Native feed, polls, email |
| Phreesia | Patient intake platform | 100K+ providers | Specialty, practice type, condition | Waiting room displays, patient-adjacent |
| UpToDate (Wolters Kluwer) | Clinical decision support | 400K+ subscribers | Specialty, search topic | Contextual display, sponsored content |
| Aunt Minnie | Imaging/radiology platform | 100K+ radiologists | Specialty (radiology focused) | Display, sponsored content |
Epocrates Deep Dive
Epocrates remains the most established POC advertising platform, with a physician-facing clinical reference app used by over 300,000 physicians. The platform's key advantage is that physicians actively consult Epocrates during prescribing decisions for drug interaction checking, dosing reference, and formulary lookup. Advertising on Epocrates reaches physicians in a clinical context where prescribing information is directly relevant. Ad formats include banners displayed alongside drug monographs, native content integrated into clinical reference sections, and formulary-specific messaging triggered when physicians look up insurance coverage.
Doximity Dialer Deep Dive
Doximity's Dialer product is a telehealth and phone communication tool used by physicians to make patient calls from their mobile device. The Dialer platform offers unique advertising opportunities including branded messaging displayed during and after phone calls with patients. Because Dialer is used during active patient communication, it represents a true point-of-care touchpoint. However, the advertising format is subtle to avoid disrupting clinical workflow, which limits message complexity and visual impact.
Targeting Capabilities
The targeting precision of POC advertising varies by platform but generally exceeds standard digital advertising in clinical relevance. The most sophisticated POC platforms offer condition-level and formulary-level targeting that enables messaging timed to specific clinical moments.
- Condition-based targeting: Serve ads when a physician looks up a specific condition or drug class in the clinical reference tool. This enables messaging precisely when the physician is considering treatment options for that condition.
- Formulary targeting: Display formulary-specific messages when a physician checks insurance coverage or formulary status. This is particularly valuable for brands with favorable formulary positions they want to highlight.
- Specialty targeting: Limit delivery to physicians in specific specialties using NPI-linked specialty data.
- Geographic targeting: Target by region, state, or health plan service area, essential for brands with regional formulary dynamics or state-specific coverage.
- Prescriber segmentation: Some platforms allow targeting based on prescribing decile or therapeutic category volume using third-party prescribing data.
Cost Structure
POC advertising carries a premium over standard digital display due to the clinical context and verified physician audience. Costs are typically structured as CPM or fixed-fee sponsorships rather than CPC.
| Platform | CPM Range | Fixed Fee Range | Minimum Commitment | Typical Campaign Duration |
|---|---|---|---|---|
| Epocrates | $50-$100 | $20K-$75K | $15K-$30K | 1-3 months |
| Doximity Dialer | $60-$120 | $25K-$100K | $20K-$40K | 1-3 months |
| Sermo | $30-$60 | $10K-$40K | $5K-$15K | 2-4 weeks |
| Phreesia | $40-$80 | $15K-$50K | $10K-$25K | 1-3 months |
| UpToDate | $60-$110 | $30K-$100K | $20K-$50K | 2-6 months |
Cost Comparison: POC advertising CPMs are 2-4x higher than standard HCP programmatic display ($15-$40 CPM) but comparable to premium HCP portal advertising ($40-$80 CPM). The premium is justified by the clinical context and proximity to prescribing decisions.
Script Impact Evidence
The critical question for pharmaceutical marketers is whether POC advertising actually drives incremental prescriptions. The evidence is mixed and varies significantly by platform, therapeutic area, and campaign design.
Positive Evidence
Several studies and platform-reported case studies have demonstrated measurable prescribing impact from POC advertising campaigns:
- Epocrates formulary messaging: A study of formulary-specific messaging on Epocrates showed a 5-12% lift in targeted prescription share among physicians exposed to the campaign versus a matched control group. The effect was strongest for formulary messages that highlighted copay advantages and coverage tier information.
- Condition-targeted campaigns: Campaigns that targeted physicians searching for specific conditions showed 3-7% prescribing lift for the advertised brand in the targeted therapeutic category. The lift was higher for newer brands and lower for established products with high market share.
- Combined POC and rep campaigns: The highest script impact was observed when POC advertising was combined with representative detailing. HCPs exposed to both POC messaging and rep visits showed 8-15% prescribing lift, significantly higher than either channel alone.
Limiting Factors
Despite positive individual case studies, several factors limit the broad effectiveness of POC advertising for script generation:
- Banner blindness: Physicians using clinical tools are focused on patient care tasks and often ignore or actively dismiss promotional messaging. Banner ad CTR within clinical tools is typically 0.05-0.15%, lower than general HCP portal advertising.
- Workflow disruption concerns: EHR vendors and clinical platform providers are cautious about allowing advertising that disrupts clinical workflow. This limits ad placement, size, and intrusiveness, reducing visual impact.
- Ad blocker usage: Many healthcare systems deploy network-level ad blocking that prevents POC advertising from loading within EHR and clinical tools on hospital networks.
- Limited attribution linkage: Connecting POC ad exposure to individual physician prescribing changes is technically challenging. Most studies rely on aggregate market-level analysis rather than individual-level attribution.
- Small addressable audience: Despite large platform memberships, the number of physicians actively using clinical tools during the campaign period and exposed to the specific ad placement is often a fraction of the claimed reach.
Benchmark Performance Data
| Metric | POC Platform Average | HCP Portal Average | Programmatic Display |
|---|---|---|---|
| Display CTR | 0.05-0.15% | 0.10-0.30% | 0.08-0.20% |
| Video completion rate | 40-55% | 55-70% | 50-65% |
| Cost per engaged HCP | $15-$35 | $8-$25 | $5-$18 |
| Attributed Rx lift (solo) | 2-5% | 1-4% | 1-3% |
| Attributed Rx lift (combined w/ rep) | 8-15% | 5-10% | 4-8% |
| Campaign ROI | 80-180% | 100-250% | 120-300% |
When POC Advertising Works Best
POC advertising is not universally effective. It works best in specific clinical and market conditions where the proximity to the prescribing decision provides genuine incremental value.
Ideal Use Cases
- Formulary changes: When a brand gains favorable formulary status or copay changes, POC messaging delivered at the point of prescribing can immediately influence drug selection. Formulary-related POC campaigns show the highest ROI in the category.
- Competitive switching: When a competitor loses formulary position or faces supply issues, POC advertising can capture switching physicians at the moment they are selecting an alternative.
- New launch support: For newly launched products, POC advertising reinforces rep messaging and provides clinical reference information at the point of prescribing when physicians need confidence to prescribe a new therapy.
- Step therapy and prior authorization: POC messaging that informs physicians about prior authorization requirements or step therapy pathways can reduce prescribing friction and improve approval rates.
Poor Use Cases
- Complex clinical messaging: POC advertising formats are too small and brief to communicate complex clinical data. Save mechanism-of-action education and clinical trial results for richer channels.
- Brand awareness for established products: Physicians are already aware of established brands. POC awareness spending for mature products typically shows minimal incremental lift.
- Specialist targeting for rare diseases: The small addressable audience for rare disease specialists limits POC campaign scale to the point where fixed costs make ROI challenging.
ROI Maximization Tip: The strongest POC advertising results come from combining POC campaigns with concurrent field force activity. POC messaging reinforces the clinical narrative delivered by representatives and increases the likelihood that a physician who saw a rep will actually prescribe your product. Plan POC campaigns to coincide with field force push periods.
Compliance and Ethical Considerations
POC advertising raises unique compliance considerations because it occurs within the clinical workflow where patient care is being delivered. Key compliance areas include:
- Patient privacy: POC platforms must ensure that advertising delivery does not expose patient health information. Ads should not be triggered by specific patient data visible in the EHR. Most platforms use physician-level targeting, not patient-condition triggering.
- Clinical workflow disruption: Regulatory guidance and medical ethics suggest that pharmaceutical advertising should not interrupt or delay clinical care. Platforms implement strict frequency caps and placement rules to minimize workflow impact.
- Transparency: POC advertising must be clearly identified as sponsored or promotional content, not clinical information. Blurring the line between clinical decision support and advertising is both a compliance risk and an ethical concern.
- Institutional policies: Many healthcare systems have institutional policies governing pharmaceutical advertising on their clinical systems. Verify that your target physician audience works in settings that permit POC advertising before investing.
Putting It All Together
EHR point-of-care advertising delivers pharmaceutical messaging at the most clinically relevant moment: when the physician is making a treatment decision. The evidence shows that POC advertising can drive measurable prescribing impact, particularly for formulary messaging and when combined with field force activity. However, the high CPMs, limited reach, and mixed attribution evidence mean POC advertising should be viewed as a complementary channel rather than a standalone solution. Use our HCP Portal ROI Comparison tool to evaluate POC advertising against other HCP digital channels, and deploy it strategically in scenarios where proximity to the prescribing decision provides genuine incremental value.